NLRP3 and Stroke: Because studies have shown that preventive inhibition of NLRP3 inflammasome can maintain its early therapeutic effect into the subacute phase, inhibition of NLRP3 inflammasome in the acute phase of CI directly affects inflammation in the ischemic penumbra after stroke (Bellut et al., 2023).